T1	Procedure 194 212	general anesthesia
T2	Procedure-Name 194 212	general anesthesia
E1	Procedure:T1 Name:T2 Temporality:E10
T3	Condition 408 425	diabetes mellitus
T4	Condition-Name 408 425	diabetes mellitus
E3	Condition:T3 Name:T4
T5	Condition 429 445	arteriosclerosis
T6	Condition-Name 429 445	arteriosclerosis
E5	Condition:T5 Name:T6
T7	Observation 295 310	Body mass index
T8	Observation-Name 295 310	Body mass index
E7	Observation:T7 Name:T8 Eq-Comparison:E12
A1	Observation-Type-Value T8 vital
T9	Condition 386 393	failure
T10	Condition-Name 386 393	failure
E9	Condition:T9 Name:T10 Temporality:E22
T11	Condition 395 407	hypertension
T12	Condition-Name 395 407	hypertension
E11	Condition:T11 Name:T12
T16	Condition 577 598	prostatic hypertrophy
T17	Condition-Name 577 598	prostatic hypertrophy
E16	Condition:T16 Name:T17
T18	Condition 514 530	urinary diseases
T19	Condition-Name 514 530	urinary diseases
E18	Condition:T18 Name:T19
T20	Condition 548 564	ureteral calculi
T21	Condition-Name 548 564	ureteral calculi
E20	Condition:T20 Name:T21
T22	Eq-Temporal-Unit 66 71	years
A2	Eq-Temporal-Unit-Value T22 year
T23	Eq-Unit 324 326	kg
T24	Eq-Operator 60 62	to
A3	Eq-Operator-Value T24 BETWEEN
T25	Eq-Value 57 59	18
T26	Eq-Value 63 65	65
T27	Eq-Value 321 323	30
T28	Eq-Comparison 57 71	18 to 65 years
E21	Eq-Comparison:T28 Operator:T24 Value:T25 Value2:T26 Temporal-Unit:T22
T29	Eq-Comparison 352 359	history
E22	Eq-Comparison:T29 Temporal-Period:T30
T30	Eq-Temporal-Period 352 359	history
A4	Eq-Temporal-Period-Value T30 past
T13	Ethnicity 35 42	Chinese
T31	Age 52 55	age
E2	Age:T31 Eq-Comparison:E21
T32	Condition 85 123	American Society of Anaesthesiologists
E4	Condition:T32 Name:T33
T33	Condition-Name 85 123	American Society of Anaesthesiologists
T34	Condition 125 128	ASA
E6	Condition:T34 Name:T35 Stage:E8
T35	Condition-Name 125 128	ASA
R1	Abbrev-Of Arg1:E6 Arg2:E4	
T36	Eq-Comparison 146 153	I or II
E8	Eq-Comparison:T36 Value:T37 Value2:T38
T37	Eq-Value 146 147	I
T38	Eq-Value 151 153	II
T39	Eq-Comparison 180 189	scheduled
E10	Eq-Comparison:T39 Temporal-Period:T40
T40	Eq-Temporal-Period 180 189	scheduled
A5	Eq-Temporal-Period-Value T40 future
T41	Eq-Comparison 311 329	exceeding 30 kg/m2
E12	Eq-Comparison:T41 Operator:T42 Value:T27 Unit:T23 Per:T43
T42	Eq-Operator 311 320	exceeding
A6	Eq-Operator-Value T42 GT
T43	Eq-Unit 327 329	m2
T44	Modifier 380 385	Renal
E13	Modifier:T44 Modifies:T10
T14	Modifier 370 375	liver
E14	Modifier:T14 Modifies:T10
T15	Modifier 363 368	heart
E15	Modifier:T15 Modifies:T10
T45	Or 376 379	and
E17	Or:T45 Arg:E14 Arg2:E13
T46	Or 426 428	or
E19	Or:T46 Arg:E3 Arg2:E5
T47	Allergy 455 462	allergy
E23	Allergy:T47 Name:E24
T48	Drug 466 471	drugs
E24	Drug:T48 
T49	Study 484 489	study
E25	Study:T49 Study-Of:E24
T50	Or 447 450	and
E26	Or:T50 Arg:E5 Arg2:E23
T51	Condition 540 546	kidney
E27	Condition:T51 Name:T52
T52	Condition-Name 540 546	kidney
R2	Example-Of Arg1:E27 Arg2:E18	
R3	Example-Of Arg1:E20 Arg2:E18	
T53	Condition 569 575	tumors
E28	Condition:T53 Name:T54
T54	Condition-Name 569 575	tumors
R4	Example-Of Arg1:E28 Arg2:E18	
T55	Or 565 568	and
E29	Or:T55 Arg:E20 Arg2:E28
R5	Example-Of Arg1:E16 Arg2:E18	
